← FDA Drug Approvals (Drugs@FDA)

CEPTAZ

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1990-09-27

Drug application

FDA Application #

NDA050646

Application type

New Drug Application

Brand name

CEPTAZ

Generic name

Ceftazidime

Active ingredients

CEFTAZIDIME

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1990-09-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown